NCT02836171View on ClinicalTrials.gov

Effect of Itraconazole on the Pharmacokinetics of Apatinib

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Neoplasms
Interventions
DRUG

Apatinib Mesylate Tablets

apatinib was administered in the morning after an overnight fast of at least 10 h

DRUG

Itraconazole Capsules

rifampicin was administered in the morning 0.5 hours after breakfast

Trial Locations (1)

200030

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02836171 - Effect of Itraconazole on the Pharmacokinetics of Apatinib | Biotech Hunter | Biotech Hunter